RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION

por Rowaiye, Adekunle B., Oli, Angus Nnamdi, Onuh, Olukemi A., Emeter, Nkoli W, Bur, Doofan, Obideyi, Oluwaseun A., Dayisi, Oluyomi Cornelius, Akpa, Jude N., Birah, Lovelyn, Omaka¹, Edward E., Iseghohi¹, Frances Otibhor, Otitoju, Akinbobola Peace, Uzor, Philip F., Okoyeh, Jude Nnaemeka
Publicado 2022

Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders—Global public health consequences

por Awoyomi, Olajoju J., Njoga, Emmanuel O., Jaja, Ishmael F., Oyeleye, Felix A., Awoyomi, Priscilla O., Ibrahim, Musawa A., Saulawa, M. A., Galadima, Haruna B., Rowaiye, Adekunle B., Olasoju, Taiwo I., Idrisa, Jamila A., Olalere, Folasade D. H., Olasoju, Mary I., Adisa, Oluwatosin H., Adetunji, Veronica E., Idemudia, Osagie O., Ezenduka, Ekene V., Oguttu, James W.
Publicado 2023